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Abstract 
 
Tumor-repopulating cells are a highly tumorigenic subpopulation of cancer cells that exhibit 
stem cell-like properties (e.g. self-renewal). Previous reports have shown that soft 3D fibrin 
matrices promote self-renewal in TRCs by promoting histone 3 lysine residue 9 (H3K9) de-
methylation and Sox2 expression [1]. However, the underlying mechanism(s) by which soft 3D 
fibrin matrices promote H3K9 de-methylation and Sox2 expression remain elusive. In this study 
we show that focal adhesion kinase (FAK) regulates Sox2 expression and H3K9 de-methylation 
through cell division control protein 42 homolog (Cdc42).  
In comparison to control melanoma cells, TRCs exhibit low FAK and Cdc42 expression. 
Overexpressing FAK or Cdc42 in TRCs cultured in soft 3D fibrin matrices promotes H3K9 
methylation, decreases Sox expression, and suppresses colony growth. Knocking down FAK or 
Cdc42 expression in control melanoma cells promotes H3K9 de-methylation, increases Sox2 
expression, and enhances colony growth in stiff 3D fibrin matrices. Overexpressing Cdc42 in 
FAK-knock down control melanoma cells inhibits H3K9 de-methylation. 
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Terminology 
 
TRCs - subpopulation of cancer cells selected by soft 3D fibrin matrices. These cells are allowed 
to proliferate in soft fibrin matrices for 5 days before use for analysis or further experiments. 
control melanoma cells - Murine melanoma cell line B16-F1 cultured on 0.1% gelatin or 50 
ug/mL collagen I coated plastic. 
expression –  mRNA gene expression 
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Chapter 1: Introduction 
 
Tumor-initiating cells (TICs) are a highly tumorigenic subpopulation of cancer cells that exhibit 
stem cell-like properties (e.g. self-renewal – cell division with maintenance of the 
undifferentiated state). These cells play a crucial role in macroscopic metastasis and the relapse 
of cancer after therapy [2]. Recently, a mechanical method was developed for selecting TICs 
from primary cancer cells and cancer cell lines by culturing individual cancer cells in soft (90-
Pa) 3D fibrin matrices. The cells that survive and proliferate in the soft 3D fibrin matrices are 
termed tumor-repopulating cells (TRCs) based on their high efficiency in repopulating local and 
metastatic tumors in wild-type syngeneic and non-syngeneic mice [3].  
It has been reported that soft (90-Pa) 3D fibrin matrices promote self-renewal in TRCs by 
promoting Sox2 expression via histone 3 lysine residue 9 (H3K9) de-methylation. In contrast, 
stiffer (1050-Pa) 3D fibrin matrices promote lower Sox2 expression via higher H3K9 
methylation. Importantly, experiments in live mice have shown that higher Sox2 expression in 
TRCs leads to more efficient tumor formation in vivo [1]. These findings suggest that mechanical 
stimuli, such as matrix softness, play an important role in promoting stem cell-like properties that 
are essential to maintaining the high tumorigenic properties of TRCs in vivo. However, the 
mechanism(s) by which soft 3D fibrin matrices promote Sox2 expression via H3K9 de-
methylation remain unknown. In this study we show that focal adhesion kinase (FAK) regulates 
Sox2 expression and H3K9 de-methylation through cell division control protein 42 homolog 
(Cdc42). Soft 3D fibrin matrices promote self-renewal by down regulating FAK expression, 
which lowers Cdc42 expression to mediate H3K9 de-methylation and Sox2 expression. 
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Chapter 2: Research Methodology 
 
When we began to study the mechanism(s) by which soft 3D fibrin matrices promote Sox2 
expression and H3K9 de-methylation in TRCs, we based our approach off of one very important 
previous finding: H3K9 de-methylation and Sox2 expression are responsive to the rigidity of 3D 
fibrin matrices [1]. This led us to hypothesize that the mechanism(s) by which soft 3D fibrin 
matrices promote Sox2 expression and H3K9 de-methylation could be controlled by mechano-
sensors (molecules that mediate signal transduction in response to mechanical stimuli). 
With the initial guidance of Dr. Jihye Seong, a former member of Professor Wang’s lab, 
we began our mechano-sensor investigation with focal adhesion kinase (FAK).  FAK is a non-
receptor tyrosine kinase that has kinase-dependent and kinase-independent functions in many 
important cellular functions, such as cell migration, survival, and regulation of gene expression 
[4]. It is very well-known that FAK is sensitive and responsive to mechanical cues from the 
environment, such as substrate rigidity, and translates these cues into intracellular biochemical 
information to regulate various cellular functions [5,6]. In addition to its mechano-sensitivity, 
FAK has been shown to have abnormal expression levels in several different types of cancer [4]. 
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Chapter 3: Results 
 
Association between FAK expression and H3K9 de-methylation 
We analyzed the FAK gene expression of control melanoma cells cultured in soft and stiff 3D 
fibrin matrices (90-Pa and 1050-Pa, respectively) after 5 days to determine if FAK is responsive 
to the 3D fibrin matrix rigidity. As previously mentioned, Sox2 expression and H3K9 
methylation levels are responsive to fibrin matrix rigidity. Therefore, we expected that a 
mechano-sensor promoting these intracellular events would also be responsive to matrix rigidity. 
As shown in Figure 1, FAK expression is higher in melanoma cells cultured in stiff 3D fibrin 
matrices than in melanoma cells cultured in soft 3D fibrin matrices. 
Knowing that both FAK expression and H3K9 methylation levels are low in soft 3D 
fibrin matrices, we overexpressed FAK in TRCs and re-plated them in soft 3D fibrin matrices to 
see if H3K9 methylation levels would change. Using a FRET-based biosensor that measures 
relative H3K9 methylation levels in live cells, we found that increased FAK expression could 
induce higher H3K9 methylation (Figure 2). We then analyzed the FAK expression in TRCs and 
control melanoma cells to determine if there is a difference between the two, as there is for Sox2 
expression and H3K9 methylation. We found that FAK expression is greater in control 
melanoma cells than in TRCs and FAK expression increases in TRCs cultured on rigid plastic 
for 7 days (Figure 3).  Previous findings show that TRCs gradually lose Sox2 expression and 
increase H3K9 methylation with culture time on plastic [1].    
To further confirm a causal relationship, we knocked down FAK in control melanoma 
cells and measured H3K9 methylation levels and Sox2 expression. Previous reports have shown 
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that control melanoma cells exhibit very low Sox2 expression and high H3K9 methylation levels 
[3,1]. Knocking down FAK decreased H3K9 methylation levels (Figure 4) and increased Sox2 
expression (Figure 5). Expression of H3K9 methyltransferases, G9a and Suv39h1, also decreased 
when FAK was knocked down in control melanoma cells (Figure 5). Previous findings have 
shown that decreased levels of G9a and Suv39h1 can lead to lower H3K9 methylation levels and 
increased Sox2 expression in control melanoma cells [1].  
 
FAK promotes self-renewal in TRCs through Cdc42 
To expand our understanding of how FAK mediates Sox2 expression and H3K9 de-methylation, 
we investigated possible intermediate proteins that may be in the signaling pathway. It is well-
known that FAK can regulate cytoskeleton assembly and disassembly through interactions with 
Rho-family GTPases [7]. Also, previous findings have shown that Cdc42 (Rho-family GTPase) 
expression is lower in TRCs in comparison to control melanoma cells [1]. With this knowledge 
we decided to investigate if Cdc42 plays a role in mediating Sox2 expression and H3K9 de-
methylation. 
To confirm that Cdc42 is downstream of FAK, we knocked down FAK in control 
melanoma cells and analyzed Cdc42 expression (Figure 6). We then analyzed the gene 
expression of control melanoma cells cultured in soft and stiff 3D fibrin matrices to determine if 
Cdc42 expression was responsive to matrix rigidity. We found that Cdc42 expression increases 
with increasing matrix rigidity, which is consistent with FAK expression in response to 
increasing matrix rigidity (Figure 7 and Figure 1).  
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Knowing that both Cdc42 expression and H3K9 methylation levels are low in soft 3D 
fibrin matrices, we overexpressed Cdc42 in TRCs and re-plated them in soft 3D fibrin matrices 
to see if H3K9 methylation levels would change. Overexpressing Cdc42 in TRCs increased 
H3K9 methylation levels (Figure 8), which is consistent with FAK overexpression in TRCs 
(Figure 2). To further confirm a causal relationship, we knocked down Cdc42 in control 
melanoma cells and measured H3K9 methylation levels. Consistent with our FAK data, Cdc42 
knockdown decreases H3K9 methylation and increases Sox2 expression (Figure 9 and Figure 
10). Expression of H3K9 methyltransferases, G9a and Suv39h1, also decreased when Cdc42 was 
knocked down in control melanoma cells (Figure 10). 
To further confirm that Cdc42 is downstream of FAK in the signaling pathway by which 
FAK regulates H3K9 methylation, we knocked down FAK in control melanoma cells while 
overexpressing Cdc42. As shown in Figure 11, overexpressing Cdc42 can inhibit H3K9 de-
methylation caused by FAK knock down.  
 
Functional role of FAK and Cdc42 in promoting self-renewal in TRCs 
As previously stated, soft fibrin matrices promote self-renewal in TRCs by regulating Sox2 
expression via H3K9 de-methylation. The functional role of Sox2 in regulating self-renewal in 
vitro has been shown by decreased colony growth of Sox2-knocked down TRCs in soft fibrin 
matrices [1]. To demonstrate the functional role of FAK and Cdc42 in regulating self-renewal in 
TRCs, we examined the effects of FAK and Cdc42 on colony growth in soft 3D fibrin matrices. 
Overexpressing FAK or Cdc42 in TRCs suppressed colony growth (Figure 12). This inhibitory 
effect is likely due to the suppression of Sox2 by FAK and Cdc42 overexpression (Figure 13). 
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Knocking down FAK or Cdc42 in control melanoma cells, which have high FAK and Cdc42 
expression in comparison to TRCs, enhanced colony growth in stiff fibrin matrices (Figure 14) 
and increased Sox2 expression (Figure 15). 
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Chapter 4: Conclusion 
 
In this study we show that FAK expression plays a crucial role in promoting self-renewal 
properties in TRCs cultured in soft 3D fibrin matrices. Low FAK or Cdc42 expression in TRCs 
or control melanoma cells promotes H3K9 de-methylation and Sox2 expression. Overexpressing 
FAK or Cdc42 in TRCs suppresses colony growth in soft 3D fibrin matrices and knocking down 
FAK or Cdc42 expression enhances colony growth of control melanoma cells cultured in stiff 3D 
fibrin matrices. Although unclear, it is likely that existing differentiated TRCs in the control 
melanoma cell population attribute to the enhanced colony growth of FAK-knock down or 
Cdc42-knock down control melanoma cells in stiff 3D fibrin matrices.  
In contrast to our findings, it has been reported that FAK is overexpressed in many 
different types of cancers and contributes to tumor progression and metastasis [4]. This 
discrepancy between our findings may result from the fact that TRCs are only a small 
subpopulation of cancer cells in tumors. Previous studies show that TRCs cultured in soft 3D 
fibrin matrices, which have very low FAK expression, are much more efficient at forming 
metastatic tumors in vivo than control melanoma cells, which have relatively high FAK 
expression [3]. 
In the future we will need to conduct experiments in live mice to determine if 
overexpressing FAK in TRCs can inhibit local and metastatic tumor formation. It would also be 
interesting to study the effects of matrix dimensionality on FAK, Cdc42, H3K9 methylation, and 
Sox2. Previous studies have shown that control melanoma cells cultured in soft 3D fibrin 
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matrices are much more tumorigenic than genetically identical cells cultured on top of soft fibrin 
matrices [3].  
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Chapter 5: Materials and Methods 
 
Cell culture 
Murine melanoma cell line B16-F1 was purchased from American Type Culture Collection. 
Briefly, cells were cultured on rigid dishes with DMEM cell culture medium supplemented with 
10% fetal bovine serum (Invitrogen), 2 mM L-glutamine (Invitrogen), 1 mM sodium 
pyruvate and 0.1 mM penicillin/streptomycin at 37 °C with 5% CO2. Cells were passaged every 
3–4 days using TrypLE (Invitrogen). Glass or plastic culture dishes were coated with collagen-1 
(50 µg/ml for glass or plastic dishes; 200 µg/ml for PA gels) or 0.1% Gelatin. 
3D fibrin gel preparation 
Salmon fibrinogen and thrombin were purchased from Reagent Proteins (CA, USA). Three-
dimensional fibrin gels were prepared as described previously (Liu et al., 2012; Tan et al., 2014). 
In brief, fibrinogen was diluted into 2 mg/ml or 16 mg/ml with T7 buffer (pH 7.4, 50 mMTris, 
150 mM NaCl). Cells were detached from 2D rigid dishes. Fibrinogen and single cell solution 
mixture was made by mixing the same volume of fibrinogen solution and cell solution, resulting 
in 1 mg/ml or 8 mg/ml fibrin gels (the stiffness of 1 and 8 mg/ml fibrin gels is 90 Pa and 1050 
Pa, respectively). 250 µl cell/fibrinogen mixture was seeded into each well of 24-well plate and 
mixed well with pre-added 5 μl thrombin (100 U/ml). The cell culture plate was then incubated 
in 37 °C cell culture incubator for 10 min. Finally, 1 ml of DMEM medium containing 10% fetal 
bovine serum and antibiotics was added. 
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Quantitative RT-PCR 
Total mRNA was isolated from cells using the RNeasy Mini Kit (QIAGEN) according to the 
supplier’s instruction. cDNA synthesis was conducted using the iScriptTM Reverse Transcription 
Supermix (Bio-Rad) according to the manufacturer’s protocol. Real-time RT–PCR was 
performed using the SsoAdvanced
TM
 Universal Probes Supermix (Bio-Rad). The data was 
normalized against mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH). All the 
primers for real-time RT-PCR were obtained from Bio-Rad (PrimePCR™ SYBR® Green Assay, 
Cat #: 100-25636). 
FRET imaging 
The H3K9 biosensor used in this study is reported elsewhere [1]. The biosensors were 
transfected into cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
protocols. A Leica inverted fluorescence microscope integrated with Dual-View MicroImager 
system (Optical Insights) was used to capture CFP and YFP (YPet) emission images. CFP/YFP 
Dual EX/EM (FRET) (OI-04-SEX2) has the following filter sets: CFP: excitation, S430/25, 
emission S470/30; YFP: excitation, S500/20, emission S535/30. The emission filter set uses a 
515-nm dichroic mirror to split the two emission images. For FRET imaging, each CFP (1344 
pixels×512 pixels) and each YFP image (1344 pixels×512 pixels) were simultaneously captured 
on the same screen by using a charge-coupled device camera (C4742-95-12ERG; Hamamatsu) 
and a 40×, 0.55 numerical aperture air-immersion objective. A customized Matlab (Mathworks) 
programme was used to analyze CFP and YFP images and to obtain YPet/CFP (H3K9 
methylation) emission ratios. 
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RNA interference 
Cells were transfected with FRET biosensor, siRNA, or complementary DNA using 
Lipofectamine 2000 (Invitrogen) following the manufacturer’s protocol. Silencer Negative 
Control No. 1 siRNA (Invitrogen, AM4611) was used a negative control in RNAi experiment. 
The construct sequence is 5’-AGUACUGCUUACGAUACGGtt-3’ for negative control siRNA, 
5’-CGAGUAUUAAAGGUCUUUCtt-3’ for FAK siRNA #1 (Invitrogen, 157446), 5’-
GCCUUAACAAUGCGUCAGUtt-3’ for FAK siRNA #2 (Invitrogen, 157447), 5’-
CCGCUAAGUUAUCCACAGAtt-3’ for Cdc42 siRNA #1 (Invitrogen, 161124), and 5’-
GGGCAAGAGGAUUAUGACAtt-3’ for Cdc42 siRNA #2 (Invitrogen, 66023). 
 
Statistical analysis 
Two-tailed Student’s t-test was used to conduct all the statistics. 
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Figures 
 
 
 
 
Figure 1: Melanoma cells have higher FAK expression in stiff fibrin gels. Control melanoma cells were cultured 
in 90-Pa and 1050-Pa 3D fibrin gels for 5 days. The mRNA was then extracted for analysis of the indicated gene by 
quantitative RT-PCR. Data was averaged from 3 independent experiments; *p < 0.05. 
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Figure 2: Overexpressing FAK in TRCs cultured in 90-Pa 3D fibrin matrices increases H3K9-methylation. 
H3K9 methylation was measured 15 hours after seeding TRCs in fibrin matrices using FRET-based biosensor; 
*p<0.05. 
 
 
Figure 3: TRCs exhibit low FAK expression in comparison to control melanoma cells. Control B16-F1 
melanoma cells were cultured in 3D soft (90-Pa) fibrin matrices (TRC) or on rigid dishes (Control). After 5 days, the 
mRNA was extracted for quantitative RT-PCR. TRCs cultured on plastic for 7 days exhibit increased FAK 
expression in comparison to TRCs in soft 3D fibrin matrices. Data averaged from 3 independent experiments; 
*p<0.05. 
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Figure 4: Knocking down FAK decreases H3K9 methylation in control melanoma cells cultured on 0.1% 
gelatin coated glass. H3K9 methylation was measured 15 hours after seeding cells on glass; *p<0.05. 
 
 
Figure 5: Knocking down FAK decreases expression of H3K9 methyltransferases, G9a and Suv39h1, and 
increases Sox2 expression in control melanoma cells cultured on 0.1% gelatin coated plastic; *p<0.05. 
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Figure 6: Knocking down FAK decreases Cdc42 expression in control melanoma cells cultured on 0.1% 
gelatin coated plastic; *p<0.05.  
 
 
Figure 7: Melanoma cells have higher Cdc42 expression in stiff fibrin gels. Control melanoma cells were 
cultured in 90 Pa and 1050 Pa 3D fibrin gels for 5 days. The mRNA was then extracted for analysis of the indicated 
gene by quantitative RT-PCR. Data was averaged from 3 independent experiments; *p < 0.05. 
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Figure 8: Overexpressing Cdc42 in TRCs cultured in 90 Pa 3D fibrin matrices increases H3K9-methylation. 
H3K9 methylation was measured 15 hours after seeding TRCs in fibrin matrices using FRET-based biosensor; 
*p<0.05. 
 
 
 
Figure 9: Knocking down Cdc42 decreased H3K9 methylation in control melanoma cells cultured on 0.1% 
gelatin coated glass. H3K9 methylation was measured 15 hours after seeding cells on glass; *p<0.05. 
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Figure 10: Knocking down Cdc42 decreased expression of H3K9 methyltransferases, G9a and Suv39h1, and 
increased Sox2 expression in control melanoma cells cultured on 0.1% gelatin coated plastic; *p<0.05. 
 
 
 
Figure 11: Overexpressing Cdc42 can inhibit H3K9 de-methylation caused by FAK knock down. H3K9 
methylation was measured 15 hours after seeding cells on glass; *p<0.05. 
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Figure 12: Overexpressing FAK or Cdc42 in TRCs suppresses colony growth in 90-Pa 3D fibrin matrices; 
*p<0.05. 
 
 
 
Figure 13: Overexpressing FAK or Cdc42 in TRCs decreases Sox2 expression in TRCs cultured for 5 days in 
90-Pa 3D fibrin matrcies; *p<0.05. 
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Figure 14: Knocking down FAK of Cdc42 in control melanoma cells enhances colony growth in 1050-Pa 3D 
fibrin matrices; *p<0.05. 
 
 
 
Figure 15: Knocking down FAK or Cdc42 increased Sox2 expression in control melanoma cells cultured in 
1050-Pa 3D fibrin matrices for 5 days; *p<0.05. 
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